Neuropsychiatric complications associated with interferon-alpha-2b treatment of malignant melanoma.
Okereke
Olivia I
OI
Department of Psychiatry, Massachusetts General Hospital, Boston 02114, USA.
D003863:Depression / Q000139:chemically induced* / Q000628:therapy; D004565:Electroconvulsive Therapy; D006801:Humans; D007262:Infusions, Intravenous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins